ReaGenics
PrivateCompany Overview
ReaGenics is a biotechnology company pioneering a novel plant cell bioreactor production for the mass-scale multiplication of molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReaGenics Comparables
Compare ReaGenics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novella Innovative Technology | 87% | |
| Ayana Bio | 83% | |
| Krokos Bio | 77% | |
ReaGenics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
ReaGenics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors increased 34% MoM.
ReaGenics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReaGenics's valuation, stock price, and market status.